CancerCARE Homepage » Clients » Groups


INTERLINK’s CancerCARE™ program is the first to collect information and apply organized management protocols to all cancer types. Most management programs focus almost exclusively on the high visibility/high cost cases, when most agree treatments in the field are equally problematic. By tying benefits reimbursement to evidence-based NCCN Guidelines® through benefit language, INTERLINK has created the first real opportunity to manage all cancer care.

Not all cancer treatments are risky or expensive, so to over manage some cancer types would provide the plan or member no benefit. To use plan assets efficiently, INTERLINK triages members into management pools with specific objectives.

Cancer treatment for patients triaged into The Explorer Group is typically neither risky nor expensive. Most of the care rendered to The Explorer group is from community providers without much complication. What comes to mind for simple cancer treatment is simple skin cancers and other non-spreading and non-lethal cancer types. Most consider level I breast cancer a "simple" treatment program, but we are all familiar with level II, III and IV cases where treatment failed and costs soared. In The Explorer Group, management objectives are to record cancer diagnosis, dispense NCCN Guidelines®, provide educational support and establish a trigger point (anything involving chemotherapy) to re-contact the CancerCARE™ program. Some of The Explorer Group diagnosis’ will be reconfirmed using the INTERLINK Pathology/DiagnosticCOE program since treatment for cancer types whose treatment protocols are based on accurate typing and staging is critical. Treatment is directly related to disease stage and typing. Incorrect staging and typing would lead to improper treatment, which diminishes patient overall survival and increases the cost of cancer treatment.

The Navigator Group is comprised of the most complicated cancer care rendered in the community care setting. Some of the most noted cost drivers for cancer care occur within The Navigator Group: over treatment, misdiagnosis, prolonged treatment, treatments not following evidence-based care and treatments not effective for the diagnosis. This group of cancer types typically do not qualify for traditional case management, so their care although expensive, remains unmanaged. A great portion of the CancerCARE™ Triage Center activities will be allocated to dispense NCCN Clinical Guidelines® and audit individual cases for compliance. Additionaly, Center activities will direct patients to Pathology/DiagnosticCOE’s to ensure proper staging and typing. INTERLINK’s benefit language, and the CancerCARE™ program will have the largest impact on those various cases other programs choose to ignore. The Licensing Agreement between INTERLINK and NCCN®, and the benefit language requiring compliance, creates this management opportunity.

The Compass Group is comprised of the most dangerous and complex cancers, along with other cancer types that have become complex. Nearly all patient’s triaged in to The Compass Group would have eventually found their way into traditional case management programs. By identifying cases at diagnosis, and introducing experienced oncology nurses and national center access early, our mission is to introduce effective evidence-based care before the patient’s condition becomes complex and expensive. Many patients will have their diagnosis affirmed by a leading national center, and will return to their community and receive their care under the watchful eyes of some of the leading specialists. INTERLINK’s care coordination program far exceeds traditional case management because most programs start long after the initial diagnosis and implementation of a care plan. The benefit language enables travel as needed and provides a thoughtful approach to clinical trial.

For more information about the CancerCARE™ program call 877-640-9610